Form 13-F position report

VIEMED HEALTHCARE IN (CANADA)

Reported by Penbrook Management LLC

VMD CUSIP 92663R105 Manager CIK 0001381055

Reported 213,857 shares, down 17,750 (7.7%) from the prior quarter.

Reported value 3.3%; share count -7.7% vs. the prior quarter.

Reduced
% of reported 13F value 1.02% This manager · Q3 2024
Shares 213,857 Quarter-end amount reported
Reported value $1,567,572 Fair value at quarter end
Consecutive quarters held 7 Through Q3 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-03-31 491135
2023-06-30 497313
2023-09-30 472695
2023-12-31 547828
2024-03-31 650076
2024-06-30 1517026
2024-09-30 1567572
2024-12-31 1715133
2025-03-31 1503881
2025-06-30 1243938
2025-09-30 1849107
2025-12-31 2017602
2026-03-31 2508785
2026-06-30 3159829
2026-09-30 2511126

Quarterly position history

How this manager's reported quarter-end position changed over time.

15 quarters
Quarterly reported position history for VIEMED HEALTHCARE IN (CANADA) held by Penbrook Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 275,948 -1,230 (-0.4%) 1.48% $2,511,126 2026-10-16
Q2 2026 Added 277,178 +4,780 (1.8%) 2.02% $3,159,829 2026-07-23
Q1 2026 Added 272,398 +850 (0.3%) 1.9% $2,508,785 2026-04-21
Q4 2025 Reduced 271,548 -780 (-0.3%) 1.39% $2,017,602 2026-01-06
Q3 2025 Added 272,328 +92,308 (51.3%) 1.29% $1,849,107 2025-10-22
Q2 2025 Reduced 180,020 -26,557 (-12.9%) 0.94% $1,243,938 2025-07-25
Q1 2025 Reduced 206,577 -7,280 (-3.4%) 1.14% $1,503,881 2025-04-01
Q4 2024 Unchanged 213,857 0 (0.0%) 1.17% $1,715,133 2025-01-23
Q3 2024 Reduced 213,857 -17,750 (-7.7%) 1.02% $1,567,572 2024-10-15
Q2 2024 Added 231,607 +162,670 (236.0%) 0.93% $1,517,026 2024-07-24
Q1 2024 Reduced 68,937 -850 (-1.2%) 0.4% $650,076 2024-04-18
Q4 2023 Reduced 69,787 -450 (-0.6%) 0.37% $547,828 2024-01-16
Q3 2023 Added 70,237 +19,387 (38.1%) 0.35% $472,695 2023-10-10
Q2 2023 Unchanged 50,850 0 (0.0%) 0.36% $497,313 2023-07-17
Q1 2023 New 50,850 +50,850 (0.0%) 0.38% $491,135 2023-04-20

Who else reported the position

135 managers reported VIEMED HEALTHCARE IN (CANADA) for Q3 2024.

Managers reporting VIEMED HEALTHCARE IN (CANADA) in Q3 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Thrivent Financial for Lutherans Added 3,425,693 +21,047 0.05% $25,110,000 15 qtrs
BlackRock Inc New 2,978,128 +2,978,128 < 0.01% $21,829,679 1 qtr
WASATCH ADVISORS INC Added 1,848,884 +303,277 0.07% $13,552,320 11 qtrs
Forager Capital Management LLC Reduced 1,717,488 -10 5.22% $13,276,182 12 qtrs
VANGUARD GROUP INC Added 1,810,401 +30,035 < 0.01% $13,270,239 18 qtrs
Kent Lake PR LLC New 1,300,000 +1,300,000 3.78% $9,529,000 1 qtr
Nantahala Capital Management LLC Reduced 1,135,122 -300,000 0.42% $8,320,444 21 qtrs
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT INC Unchanged 796,025 0 0.32% $5,834,863 9 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 772,808 -2,673 < 0.01% $5,665,839 18 qtrs
The Goldman Sachs Group Inc Added 746,536 +19,925 < 0.01% $5,472,109 21 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2024
Filed
October 15, 2024
Filing type
13F-HR
Position type
Stock

Voting authority reported

Sole
0
Shared
0
None
213,857

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.